Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 588

1.

Anti-CD19 CAR T-Cell Therapy for B-Cell Non-Hodgkin Lymphoma.

Abramson JS.

Transfus Med Rev. 2019 Aug 29. pii: S0887-7963(19)30076-8. doi: 10.1016/j.tmrv.2019.08.003. [Epub ahead of print] Review.

PMID:
31677848
2.

National Partnership for Maternal Safety: Consensus Bundle on Venous Thromboembolism.

Urato AC, Abi-Jaoude E, Abramson J, Alter H, Andrew LB, Antonuccio D, Bero L, Biron P, Boylan LS, Braillon A, Brophy JM, Brownlee S, Cassels A, Cook-Deegan R, Cosgrove L, De Fiore L, Deyo RA, Elshaug A, Farquhar C, Fatovich DM, Fingerman E, Gérvas J, Gøtzsche PC, Gracia R, Heath I, Himmelstein DU, Hoffman JR, Järvinen T, Jureidini J, Kotaska A, Kuehlein T, Lenzer J, Levenstein S, Lexchin J, Mintzes B, Naudet F, Niquette M, Orellana Navarrete LP, Pearson CA, Rail G, Roberts R, Shah N, Sharav V, Siwek J, Topolski S, Tsai AC.

Obstet Gynecol. 2019 Nov;134(5):1115-1117. doi: 10.1097/AOG.0000000000003540. No abstract available.

PMID:
31651818
3.

Successful anti-CD19 CAR T-cell therapy in HIV-infected patients with refractory high-grade B-cell lymphoma.

Abramson JS, Irwin KE, Frigault MJ, Dietrich J, McGree B, Jordan JT, Yee AJ, Chen YB, Raje NS, Barnes JA, Davis B.

Cancer. 2019 Nov 1;125(21):3692-3698. doi: 10.1002/cncr.32411. Epub 2019 Sep 10. No abstract available.

PMID:
31503324
4.

Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma.

Frigault MJ, Dietrich J, Martinez-Lage M, Leick M, Choi BD, DeFilipp Z, Chen YB, Abramson J, Crombie J, Armand P, Nayak L, Panzini C, Riley LS, Gallagher K, Maus MV.

Blood. 2019 Sep 12;134(11):860-866. doi: 10.1182/blood.2019001694. Epub 2019 Jul 18.

PMID:
31320380
5.

Hitting back at lymphoma: How do modern diagnostics identify high-risk diffuse large B-cell lymphoma subsets and alter treatment?

Abramson JS.

Cancer. 2019 Sep 15;125(18):3111-3120. doi: 10.1002/cncr.32145. Epub 2019 Jul 9. Review.

PMID:
31287161
6.

Ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial treatment for younger patients with chronic lymphocytic leukaemia: a single-arm, multicentre, phase 2 trial.

Davids MS, Brander DM, Kim HT, Tyekucheva S, Bsat J, Savell A, Hellman JM, Bazemore J, Francoeur K, Alencar A, Shune L, Omaira M, Jacobson CA, Armand P, Ng S, Crombie J, LaCasce AS, Arnason J, Hochberg EP, Takvorian RW, Abramson JS, Fisher DC, Brown JR; Blood Cancer Research Partnership of the Leukemia & Lymphoma Society.

Lancet Haematol. 2019 Aug;6(8):e419-e428. doi: 10.1016/S2352-3026(19)30104-8. Epub 2019 Jun 14.

PMID:
31208944
7.

NCCN Guidelines Insights: B-Cell Lymphomas, Version 3.2019.

Zelenetz AD, Gordon LI, Abramson JS, Advani RH, Bartlett NL, Caimi PF, Chang JE, Chavez JC, Christian B, Fayad LE, Glenn MJ, Habermann TM, Lee Harris N, Hernandez-Ilizaliturri F, Kaminski MS, Kelsey CR, Khan N, Krivacic S, LaCasce AS, Mehta A, Nademanee A, Rabinovitch R, Reddy N, Reid E, Roberts KB, Smith SD, Snyder ED, Swinnen LJ, Vose JM, Dwyer MA, Sundar H.

J Natl Compr Canc Netw. 2019 Jun 1;17(6):650-661. doi: 10.6004/jnccn.2019.0029.

PMID:
31200358
8.

Brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine for nonbulky limited-stage classical Hodgkin lymphoma.

Abramson JS, Arnason JE, LaCasce AS, Redd R, Barnes JA, Sokol L, Joyce R, Avigan D, Neuberg D, Takvorian RW, Hochberg EP, Bello CM.

Blood. 2019 Aug 15;134(7):606-613. doi: 10.1182/blood.2019001272. Epub 2019 Jun 11.

PMID:
31186274
9.

Multiple neurosteroid and cholesterol binding sites in voltage-dependent anion channel-1 determined by photo-affinity labeling.

Cheng WWL, Budelier MM, Sugasawa Y, Bergdoll L, Queralt-Martín M, Rosencrans W, Rostovtseva TK, Chen ZW, Abramson J, Krishnan K, Covey DF, Whitelegge JP, Evers AS.

Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Oct;1864(10):1269-1279. doi: 10.1016/j.bbalip.2019.06.004. Epub 2019 Jun 5.

10.

Chimeric Antigen Receptor T-Cell Therapies for Aggressive B-Cell Lymphomas: Current and Future State of the Art.

Abramson JS, Lunning M, Palomba ML.

Am Soc Clin Oncol Educ Book. 2019 Jan;39:446-453. doi: 10.1200/EDBK_238693. Epub 2019 May 17.

PMID:
31099671
11.

Phase 1 study of lenalidomide, bendamustine, and rituximab in previously untreated patients with chronic lymphocytic leukemia.

Soumerai JD, Davids MS, Werner L, Fisher DC, Armand P, Amrein PC, Neuberg D, Hochberg EP, Brown JR, Abramson JS.

Leuk Lymphoma. 2019 May 10:1-8. doi: 10.1080/10428194.2019.1608533. [Epub ahead of print]

PMID:
31074316
12.

Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response.

Krubiner CB, Faden RR, Karron RA, Little MO, Lyerly AD, Abramson JS, Beigi RH, Cravioto AR, Durbin AP, Gellin BG, Gupta SB, Kaslow DC, Kochhar S, Luna F, Saenz C, Sheffield JS, Tindana PO; PREVENT Working Group.

Vaccine. 2019 May 3. pii: S0264-410X(19)30045-3. doi: 10.1016/j.vaccine.2019.01.011. [Epub ahead of print] Review.

13.

Efficacy results of a phase 2 trial of first-line idelalisib plus ofatumumab in chronic lymphocytic leukemia.

Lampson BL, Kim HT, Davids MS, Abramson JS, Freedman AS, Jacobson CA, Armand PA, Joyce RM, Arnason JE, Rassenti LZ, Kipps TJ, Fein J, Fernandes SM, Hanna JR, Fisher DC, Brown JR.

Blood Adv. 2019 Apr 9;3(7):1167-1174. doi: 10.1182/bloodadvances.2018030221.

14.

Rbpj expression in regulatory T cells is critical for restraining TH2 responses.

Delacher M, Schmidl C, Herzig Y, Breloer M, Hartmann W, Brunk F, Kägebein D, Träger U, Hofer AC, Bittner S, Weichenhan D, Imbusch CD, Hotz-Wagenblatt A, Hielscher T, Breiling A, Federico G, Gröne HJ, Schmid RM, Rehli M, Abramson J, Feuerer M.

Nat Commun. 2019 Apr 8;10(1):1621. doi: 10.1038/s41467-019-09276-w.

15.

Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303.

Bartlett NL, Wilson WH, Jung SH, Hsi ED, Maurer MJ, Pederson LD, Polley MC, Pitcher BN, Cheson BD, Kahl BS, Friedberg JW, Staudt LM, Wagner-Johnston ND, Blum KA, Abramson JS, Reddy NM, Winter JN, Chang JE, Gopal AK, Chadburn A, Mathew S, Fisher RI, Richards KL, Schöder H, Zelenetz AD, Leonard JP.

J Clin Oncol. 2019 Jul 20;37(21):1790-1799. doi: 10.1200/JCO.18.01994. Epub 2019 Apr 2.

16.

Nighttime administration of high-dose, sustained-release melatonin does not decrease nocturnal blood pressure in African-American patients: Results from a preliminary randomized, crossover trial.

Rahbari-Oskoui FF, Abramson JL, Bruckman AM, Chapman AB, Cotsonis GA, Johnson SA, Bliwise DL.

Complement Ther Med. 2019 Apr;43:157-164. doi: 10.1016/j.ctim.2019.01.026. Epub 2019 Jan 31.

PMID:
30935524
17.

Tuft cells: From the mucosa to the thymus.

Nevo S, Kadouri N, Abramson J.

Immunol Lett. 2019 Jun;210:1-9. doi: 10.1016/j.imlet.2019.02.003. Epub 2019 Mar 21. Review.

PMID:
30904566
18.

Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells.

Karschnia P, Jordan JT, Forst DA, Arrillaga-Romany IC, Batchelor TT, Baehring JM, Clement NF, Gonzalez Castro LN, Herlopian A, Maus MV, Schwaiblmair MH, Soumerai JD, Takvorian RW, Hochberg EP, Barnes JA, Abramson JS, Frigault MJ, Dietrich J.

Blood. 2019 May 16;133(20):2212-2221. doi: 10.1182/blood-2018-12-893396. Epub 2019 Feb 26.

PMID:
30808634
19.

Reply.

Fung THM, Ojha S, Abramson J, Holden R.

Ophthalmology. 2019 Mar;126(3):e20-e21. doi: 10.1016/j.ophtha.2018.10.025. No abstract available.

PMID:
30803525
20.

Selective inhibition of the FcεRI-induced de novo synthesis of mediators by an inhibitory receptor.

Abramson J, Licht A, Pecht I.

EMBO J. 2019 Feb 1;38(3). pii: e101419. doi: 10.15252/embj.2018101419. No abstract available.

21.

NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019.

Wierda WG, Byrd JC, Abramson JS, Bilgrami SF, Bociek G, Brander D, Brown J, Chanan-Khan AA, Chavez JC, Coutre SE, Davis RS, Fletcher CD, Hill B, Kahl BS, Kamdar M, Kaplan LD, Khan N, Kipps TJ, Ma S, Malek S, Mato A, Mosse C, Neppalli VT, Shadman M, Siddiqi T, Stephens D, Wagner N, Dwyer MA, Sundar H.

J Natl Compr Canc Netw. 2019 Jan;17(1):12-20. doi: 10.6004/jnccn.2019.0002.

PMID:
30659125
22.

Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma.

Grande BM, Gerhard DS, Jiang A, Griner NB, Abramson JS, Alexander TB, Allen H, Ayers LW, Bethony JM, Bhatia K, Bowen J, Casper C, Choi JK, Culibrk L, Davidsen TM, Dyer MA, Gastier-Foster JM, Gesuwan P, Greiner TC, Gross TG, Hanf B, Harris NL, He Y, Irvin JD, Jaffe ES, Jones SJM, Kerchan P, Knoetze N, Leal FE, Lichtenberg TM, Ma Y, Martin JP, Martin MR, Mbulaiteye SM, Mullighan CG, Mungall AJ, Namirembe C, Novik K, Noy A, Ogwang MD, Omoding A, Orem J, Reynolds SJ, Rushton CK, Sandlund JT, Schmitz R, Taylor C, Wilson WH, Wright GW, Zhao EY, Marra MA, Morin RD, Staudt LM.

Blood. 2019 Mar 21;133(12):1313-1324. doi: 10.1182/blood-2018-09-871418. Epub 2019 Jan 7.

23.

Advances in risk assessment and prophylaxis for central nervous system relapse in diffuse large B-cell lymphoma.

Qualls D, Abramson JS.

Haematologica. 2019 Jan;104(1):25-34. doi: 10.3324/haematol.2018.195834. Epub 2018 Dec 20. Review.

24.

Design and clinical validation of a point-of-care device for the diagnosis of lymphoma via contrast-enhanced microholography and machine learning.

Im H, Pathania D, McFarland PJ, Sohani AR, Degani I, Allen M, Coble B, Kilcoyne A, Hong S, Rohrer L, Abramson JS, Dryden-Peterson S, Fexon L, Pivovarov M, Chabner B, Lee H, Castro CM, Weissleder R.

Nat Biomed Eng. 2018 Sep;2(9):666-674. doi: 10.1038/s41551-018-0265-3. Epub 2018 Jul 23.

25.

Global Funders Consortium for Universal Influenza Vaccine Development.

Bresee JS, McKinlay MA, Abramson J, Klugman KP, Wairagkar N; Global Funders Consortium for Universal Influenza Vaccine Development.

Vaccine. 2019 Jan 7;37(2):211-213. doi: 10.1016/j.vaccine.2018.11.037. Epub 2018 Nov 30. No abstract available.

PMID:
30503660
26.

Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study.

Dunleavy K, Fanale MA, Abramson JS, Noy A, Caimi PF, Pittaluga S, Parekh S, Lacasce A, Hayslip JW, Jagadeesh D, Nagpal S, Lechowicz MJ, Gaur R, Lucas A, Melani C, Roschewski M, Steinberg SM, Jaffe ES, Kahl B, Friedberg JW, Little RF, Bartlett NL, Wilson WH.

Lancet Haematol. 2018 Dec;5(12):e609-e617. doi: 10.1016/S2352-3026(18)30177-7.

PMID:
30501868
27.

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL.

Woyach JA, Ruppert AS, Heerema NA, Zhao W, Booth AM, Ding W, Bartlett NL, Brander DM, Barr PM, Rogers KA, Parikh SA, Coutre S, Hurria A, Brown JR, Lozanski G, Blachly JS, Ozer HG, Major-Elechi B, Fruth B, Nattam S, Larson RA, Erba H, Litzow M, Owen C, Kuzma C, Abramson JS, Little RF, Smith SE, Stone RM, Mandrekar SJ, Byrd JC.

N Engl J Med. 2018 Dec 27;379(26):2517-2528. doi: 10.1056/NEJMoa1812836. Epub 2018 Dec 1.

28.

Harnessing photoinduced electron transfer to optically determine protein sub-nanoscale atomic distances.

Pantazis A, Westerberg K, Althoff T, Abramson J, Olcese R.

Nat Commun. 2018 Nov 9;9(1):4738. doi: 10.1038/s41467-018-07218-6.

29.

Assessing the role of residue E73 and lipid headgroup charge in VDAC1 voltage gating.

Queralt-Martín M, Bergdoll L, Jacobs D, Bezrukov SM, Abramson J, Rostovtseva TK.

Biochim Biophys Acta Bioenerg. 2019 Jan;1860(1):22-29. doi: 10.1016/j.bbabio.2018.11.001. Epub 2018 Nov 6.

PMID:
30412693
30.

Systemic Effects of Optos versus Indirect Ophthalmoscopy for Retinopathy of Prematurity Screening.

Fung THM, Abramson J, Ojha S, Holden R.

Ophthalmology. 2018 Nov;125(11):1829-1832. doi: 10.1016/j.ophtha.2018.06.001. Epub 2018 Jul 6. No abstract available.

PMID:
30322451
31.

Impact of HIV Infection on the Clinical Presentation and Survival of Non-Hodgkin Lymphoma: A Prospective Observational Study From Botswana.

Milligan MG, Bigger E, Abramson JS, Sohani AR, Zola M, Kayembe MKA, Medhin H, Suneja G, Lockman S, Chabner BA, Dryden-Peterson SL.

J Glob Oncol. 2018 Sep;4:1-11. doi: 10.1200/JGO.17.00084.

32.

Single-cell mapping of the thymic stroma identifies IL-25-producing tuft epithelial cells.

Bornstein C, Nevo S, Giladi A, Kadouri N, Pouzolles M, Gerbe F, David E, Machado A, Chuprin A, Tóth B, Goldberg O, Itzkovitz S, Taylor N, Jay P, Zimmermann VS, Abramson J, Amit I.

Nature. 2018 Jul;559(7715):622-626. doi: 10.1038/s41586-018-0346-1. Epub 2018 Jul 18.

PMID:
30022162
33.

EEG findings in CAR T-cell therapy-related encephalopathy.

Herlopian A, Dietrich J, Abramson JS, Cole AJ, Westover MB.

Neurology. 2018 Jul 31;91(5):227-229. doi: 10.1212/WNL.0000000000005910. Epub 2018 Jun 29. No abstract available.

34.

Panobinostat in combination with rituximab in heavily pretreated diffuse large B-cell lymphoma: Results of a phase II study.

Barnes JA, Redd R, Fisher DC, Hochberg EP, Takvorian T, Neuberg D, Jacobsen E, Abramson JS.

Hematol Oncol. 2018 Oct;36(4):633-637. doi: 10.1002/hon.2515. Epub 2018 Jun 28.

PMID:
29956350
35.

Human Herpes Virus 8 in HIV-1 infected individuals receiving cancer chemotherapy and stem cell transplantation.

Hogan LE, Hanhauser E, Hobbs KS, Palmer CD, Robles Y, Jost S, LaCasce AS, Abramson J, Hamdan A, Marty FM, Kuritzkes DR, Henrich TJ.

PLoS One. 2018 May 10;13(5):e0197298. doi: 10.1371/journal.pone.0197298. eCollection 2018.

36.

Substrate-bound outward-open structure of a Na+-coupled sialic acid symporter reveals a new Na+ site.

Wahlgren WY, Dunevall E, North RA, Paz A, Scalise M, Bisignano P, Bengtsson-Palme J, Goyal P, Claesson E, Caing-Carlsson R, Andersson R, Beis K, Nilsson UJ, Farewell A, Pochini L, Indiveri C, Grabe M, Dobson RCJ, Abramson J, Ramaswamy S, Friemann R.

Nat Commun. 2018 May 1;9(1):1753. doi: 10.1038/s41467-018-04045-7.

37.

Conformational transitions of the sodium-dependent sugar transporter, vSGLT.

Paz A, Claxton DP, Kumar JP, Kazmier K, Bisignano P, Sharma S, Nolte SA, Liwag TM, Nayak V, Wright EM, Grabe M, Mchaourab HS, Abramson J.

Proc Natl Acad Sci U S A. 2018 Mar 20;115(12):E2742-E2751. doi: 10.1073/pnas.1718451115. Epub 2018 Mar 5.

38.

Spatial perseveration error by alpacas (Vicugna pacos) in an A-not-B detour task.

Abramson JZ, Paulina Soto D, Beatriz Zapata S, Lloreda MVH.

Anim Cogn. 2018 May;21(3):433-439. doi: 10.1007/s10071-018-1170-6. Epub 2018 Feb 27.

PMID:
29488112
39.

Correction to 'Imitation of novel conspecific and human speech sounds in the killer whale (Orcinus orca)'.

Abramson JZ, Hernández-Lloreda MV, García L, Colmenares F, Aboitiz F, Call J.

Proc Biol Sci. 2018 Feb 28;285(1873). pii: 20180287. doi: 10.1098/rspb.2018.0287. No abstract available.

40.

Statins in Persons at Low Risk of Cardiovascular Disease.

Abramson J.

Am Fam Physician. 2017 Nov 1;96(9):Online. No abstract available.

PMID:
29431361
41.

Imitation of novel conspecific and human speech sounds in the killer whale (Orcinus orca).

Abramson JZ, Hernández-Lloreda MV, García L, Colmenares F, Aboitiz F, Call J.

Proc Biol Sci. 2018 Jan 31;285(1871). pii: 20172171. doi: 10.1098/rspb.2017.2171. Erratum in: Proc Biol Sci. 2018 Feb 28;285(1873):.

42.

Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL.

Pilichowska M, Pittaluga S, Ferry JA, Hemminger J, Chang H, Kanakry JA, Sehn LH, Feldman T, Abramson JS, Kritharis A, Hernandez-Ilizaliturri FJ, Lossos IS, Press OW, Fenske TS, Friedberg JW, Vose JM, Blum KA, Jagadeesh D, Woda B, Gupta GK, Gascoyne RD, Jaffe ES, Evens AM.

Blood Adv. 2017 Dec 11;1(26):2600-2609. doi: 10.1182/bloodadvances.2017009472. eCollection 2017 Dec 12.

43.

Protonation state of glutamate 73 regulates the formation of a specific dimeric association of mVDAC1.

Bergdoll LA, Lerch MT, Patrick JW, Belardo K, Altenbach C, Bisignano P, Laganowsky A, Grabe M, Hubbell WL, Abramson J.

Proc Natl Acad Sci U S A. 2018 Jan 9;115(2):E172-E179. doi: 10.1073/pnas.1715464115. Epub 2017 Dec 26.

44.

EL20, a potent antiarrhythmic compound, selectively inhibits calmodulin-deficient ryanodine receptor type 2.

Klipp RC, Li N, Wang Q, Word TA, Sibrian-Vazquez M, Strongin RM, Wehrens XHT, Abramson JJ.

Heart Rhythm. 2018 Apr;15(4):578-586. doi: 10.1016/j.hrthm.2017.12.017. Epub 2017 Dec 14.

45.

More on Anti-CD19 CAR T Cells in CNS Diffuse Large-B-Cell Lymphoma.

Abramson JS, Chen YB.

N Engl J Med. 2017 Nov 23;377(21):2102. doi: 10.1056/NEJMc1712460. No abstract available.

PMID:
29166240
46.

Ion Transport across Biological Membranes by Carborane-Capped Gold Nanoparticles.

Grzelczak MP, Danks SP, Klipp RC, Belic D, Zaulet A, Kunstmann-Olsen C, Bradley DF, Tsukuda T, Viñas C, Teixidor F, Abramson JJ, Brust M.

ACS Nano. 2017 Dec 26;11(12):12492-12499. doi: 10.1021/acsnano.7b06600. Epub 2017 Nov 28.

47.

Quantitative analysis of protein-protein interactions and post-translational modifications in rare immune populations.

Avin A, Levy M, Porat Z, Abramson J.

Nat Commun. 2017 Nov 15;8(1):1524. doi: 10.1038/s41467-017-01808-6.

48.

Hairy Cell Leukemia, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

Wierda WG, Byrd JC, Abramson JS, Bhat S, Bociek G, Brander D, Brown J, Chanan-Khan A, Coutre SE, Davis RS, Fletcher CD, Hill B, Kahl BS, Kamdar M, Kaplan LD, Khan N, Kipps TJ, Lancet J, Ma S, Malek S, Mosse C, Shadman M, Siddiqi T, Stephens D, Wagner N, Zelenetz AD, Dwyer MA, Sundar H.

J Natl Compr Canc Netw. 2017 Nov;15(11):1414-1427. doi: 10.6004/jnccn.2017.0165.

PMID:
29118233
49.

Statins in Persons at Low Risk of Cardiovascular Disease.

Abramson J.

Am Fam Physician. 2017 Nov 1;96(9):Online. Review. No abstract available.

50.

Thymospheres Are Formed by Mesenchymal Cells with the Potential to Generate Adipocytes, but Not Epithelial Cells.

Sheridan JM, Keown A, Policheni A, Roesley SNA, Rivlin N, Kadouri N, Ritchie ME, Jain R, Abramson J, Heng TSP, Gray DHD.

Cell Rep. 2017 Oct 24;21(4):934-942. doi: 10.1016/j.celrep.2017.09.090.

Supplemental Content

Loading ...
Support Center